Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | AHR | P35869 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.40 |
| ▸ | P4HTM | Q9NXG6 | 4/20 | 0.39 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.39 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.39 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | P4HA1 | P13674 | 1/20 | 0.39 |
| ▸ | MIF | P14174 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9342407 | 0.91 | MAPK1 (0.60) | MAPK1L3MBTL1KDM4ETSHRSMN1; SMN2 | |
| SCHEMBL20202080 | 0.84 | MAPK1 (0.43) | MAPK1L3MBTL1KDM4ESMN1; SMN2RXFP1 | |
| SCHEMBL16998556 | 0.83 | MAPK1 (0.53) | MAPK1L3MBTL1KDM4ESMN1; SMN2RXFP1 | |
| SCHEMBL989398 | 0.80 | MAPK1 (0.79) | MAPK1L3MBTL1KDM4EMEN1AHR | |
| SCHEMBL7356957 | 0.80 | MAPK1 (0.51) | MAPK1L3MBTL1KDM4ETSHRHCAR3 | |
| SCHEMBL14001767 | 0.79 | TSHR (0.56) | MAPK1L3MBTL1TSHRSMN1; SMN2KMT2A | |
| SCHEMBL9918169 | 0.79 | TSHR (0.56) | MAPK1L3MBTL1TSHRSMN1; SMN2KMT2A | |
| SCHEMBL20202083 | 0.78 | TSHR (0.45) | KDM4ETSHRSMN1; SMN2RXFP1KMT2A | |
| SCHEMBL14480266 | 0.76 | MAPT (0.50) | L3MBTL1HCAR3GAA | |
| SCHEMBL338813 | 0.76 | ALDH1A1 (0.57) | MAPK1L3MBTL1KDM4ETSHRSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11807886-B2 | Process for the preparation of copolymers derived from 2,4- or 2,5-pyridinedicarboxylic acid | BIOME BIOPLASTICS LIMITED (GB) | 2023-11-07 | — | — | US | disclosed |
| US-11807886-B2 | Process for the preparation of copolymers derived from 2,4- or 2,5-pyridinedicarboxylic acid | BIOME BIOPLASTICS LIMITED (GB) | 2023-11-07 | — | — | US | disclosed |
| US-20180148752-A1 | PROCESS FOR THE PREPARATION OF 2,4- OR 2,5-PYRIDINEDICARBOXYLIC ACID AND COPOLYMERS DERIVED THEREFROM | BIOME BIOPLASTICS LIMITED (GB) | 2018-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11807886-B2 | Process for the preparation of copolymers derived from 2,4- or 2,5-pyridinedicarboxylic acid | HPD, PGD, PCCA | MAPK1 3440/4885L3MBTL1 4557/4885KDM4E 378/4885 |
| US-20180148752-A1 | PROCESS FOR THE PREPARATION OF 2,4- OR 2,5-PYRIDINEDICARBOXYLIC ACID AND COPOLYMERS DERIVED THEREFROM | HPD, PCCA, MVD | MAPK1 2904/4885L3MBTL1 4344/4885KDM4E 657/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.